title: The John Charnley Award: Metal-on-metal hip resurfacing versus large-diameter head metal-on-metal total hip arthroplasty: a randomized clinical trial.
abstract: Resurfacing arthroplasty has become an attractive option for young patients who want to maintain a high activity level. One recent study reported modestly increased activity levels for patients with resurfacing compared to standard total hip arthroplasty (THA). We conducted a prospective randomized clinical trial to compare clinical outcomes of resurfacing versus large-head metal-on-metal total hip arthroplasty. We randomized 107 patients deemed eligible for resurfacing arthroplasty to have either resurfacing or standard THA. Patients were assessed for quality-of-life outcomes using the PAT-5D index, WOMAC, SF-36, and UCLA activity score. The minimum followup was 0.8 years (mean, 1.1 years; range, 0.8-2.2 years). Of the 73 patients followed at least one year, both groups reported improvement in quality of life on all outcome measures. There was no difference in quality of life between the two arms in the study. Serum levels of cobalt and chromium were measured in a subset of 30 patients. In both groups cobalt and chromium was elevated compared to baseline. Patients receiving a large-head metal-on-metal total hip had elevated ion levels compared to the resurfacing arm of the study. At 1 year, the median serum cobalt increased 46-fold from baseline in patients in the large-head total hip group, while the median serum chromium increased 10-fold. At 1 year, serum cobalt was 10-fold higher and serum chromium 2.6-fold higher than in the resurfacing arm. Due to these excessively high metal ion levels, the authors recommend against further use of this particular large-head total hip arthroplasty.
  
  
  METHODS
  Level I, randomized clinical trial. See Guidelines for Authors for a complete description of levels of evidence.
authors.affiliation: Division of Lower Limb Reconstruction and Oncology, Department of Orthopaedics, University of British Columbia, Room 3114, 910 West 10th Avenue, Vancouver, BC, V5Z 4E3, Canada. garbuz@shaw.ca
authors.forename: Donald S
authors.initials: DS
authors.lastname: Garbuz
authors.forename: Michael
authors.initials: M
authors.lastname: Tanzer
authors.forename: Nelson V
authors.initials: NV
authors.lastname: Greidanus
authors.forename: Bassam A
authors.initials: BA
authors.lastname: Masri
authors.forename: Clive P
authors.initials: CP
authors.lastname: Duncan
mesh_terms: D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects / Q000295:instrumentation*; D001363:Awards and Prizes; D015415:Biomarkers / Q000097:blood; D002857:Chromium / Q000097:blood; D003035:Cobalt / Q000097:blood; D005260:Female; D006621:Hip Joint / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007592:Joint Diseases / Q000503:physiopathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011474:Prosthesis Design; D011475:Prosthesis Failure; D011788:Quality of Life; D020127:Recovery of Function; D013314:Stress, Mechanical; D011795:Surveys and Questionnaires; D013997:Time Factors; D016896:Treatment Outcome; D015854:Up-Regulation
chemical_list: D015415:Biomarkers; D002857:Chromium; D003035:Cobalt
references.citation: Spine (Phila Pa 1976). 2008 May 20;33(12):1384-90
references.pmid: 18496353
references.citation: Instr Course Lect. 2001;50:165-79
references.pmid: 11372311
references.citation: J Rheumatol. 1997 Apr;24(4):799-802
references.pmid: 9101522
references.citation: Clin Orthop Relat Res. 1999 Jul;(364):164-74
references.pmid: 10416406
references.citation: J Bone Joint Surg Am. 1999 Mar;81(3):400-3
references.pmid: 10199279
references.citation: Clin Orthop Relat Res. 1996 Dec;(333):108-17
references.pmid: 8981886
references.citation: Clin Orthop Relat Res. 2002 Aug;(401):149-61
references.pmid: 12151892
references.citation: Qual Life Res. 1994 Feb;3(1):7-12
references.pmid: 8142947
references.citation: J Arthroplasty. 1999 Dec;14(8):915-7
references.pmid: 10614880
references.citation: Clin Orthop Relat Res. 1992 Mar;(276):7-18
references.pmid: 1537177
references.citation: J Arthroplasty. 1998 Dec;13(8):890-5
references.pmid: 9880181
references.citation: Hip Int. 2006;16 Suppl 4:73-81
references.pmid: 19219833
references.citation: J Bone Joint Surg Br. 2005 Apr;87(4):463-4
references.pmid: 15795193
references.citation: Clin Orthop Relat Res. 2001 Dec;(393):66-70
references.pmid: 11764372
references.citation: J Bone Joint Surg Br. 2008 Jul;90(7):847-51
references.pmid: 18591590
references.citation: J Bone Joint Surg Br. 2006 Jan;88(1):31-4
references.pmid: 16365116
references.citation: J Biomed Mater Res. 1999 Dec 15;47(4):543-50
references.pmid: 10497290
references.citation: J Bone Joint Surg Am. 2003 Nov;85(11):2168-73
references.pmid: 14630848
references.citation: Clin Orthop Relat Res. 1996 Aug;(329 Suppl):S256-63
references.pmid: 8769339
references.citation: J Rheumatol. 1988 Dec;15(12):1833-40
references.pmid: 3068365
references.citation: Mol Cell Biochem. 2001 Jun;222(1-2):127-36
references.pmid: 11678594
references.citation: J Bone Joint Surg Am. 2002;84-A Suppl 2:2-20
references.pmid: 12479335
references.citation: Clin Orthop Relat Res. 1994 Jan;(298):156-64
references.pmid: 8118970
references.citation: J Bone Joint Surg Br. 2007 Nov;89(11):1431-8
references.pmid: 17998177
references.citation: J Bone Joint Surg Am. 2004 Jan;86(1):28-39
references.pmid: 14711942
references.citation: J Bone Joint Surg Br. 2007 Apr;89(4):441-8
references.pmid: 17463109
references.citation: J Bone Joint Surg Br. 2004 Mar;86(2):177-84
references.pmid: 15046429
references.citation: J Bone Joint Surg Am. 1998 Oct;80(10):1447-58
references.pmid: 9801213
references.citation: Clin Orthop Relat Res. 2003 Jan;(406):282-96
references.pmid: 12579029
references.citation: Instr Course Lect. 2001;50:185-95
references.pmid: 11372314
references.citation: J Bone Joint Surg Br. 2005 Feb;87(2):167-70
references.pmid: 15736736
references.citation: J Bone Joint Surg Am. 2008 Aug;90 Suppl 3:142-8
references.pmid: 18676949